`
`Lmin Plurnaoeuicds, Inc.
`
`Pl'IARflAC UIICALS I
`E
`
`"C
`
`.
`
`Our mission is to become a transnational pharmaceutical company
`.
`_
`.
`_
`through the development and Introduction of a wide portfolio of branded
`a
`Q
`- '
`n
`-
`n
`._<_u.
`
`Lupin Phannaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin
`Limited, which is among the top five pharmaceutical companies in India.
`Through our sales and marketing headquarters in Baltimore, MD, Lupin
`Phannaceuticals, Inc. is dedicated to delivering high-quality, branded and
`generic medications trusted by healthcare professionals and patients
`across geographies.
`
`is strongly research
`India,
`Lupin Limited, headquartered in Mumbai,
`focused. It has a program for developing New Chemical Entities. The
`company has a state—of-the-art R&D center in Pune and is a leading global
`player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs
`(ACE—inhibitors and cholesterol
`reducing agents) and has a notable
`presence in the areas of diabetes, anti-inflammatory and respiratory
`therapy.
`
`
`the US market."
`
`We are building on our parent company's strengths of vertical integration
`in discovery research, process chemistry, active phannaceutical ingredient
`production,
`fonnulation development and regulatory filings. Lupin
`Pharmaceuticals, Inc. is committed to achieving its vision and mission of
`becoming an innovation led transnational phannaceutical company.
`
`Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc. says "founded on the
`strengths of our parent company Lupin Limited, Lupin Phannaceuticals,
`Inc. intends to bring a portfolio of generics as well as branded products to
`
`For the financial year ended 31st March 2015, Lupin's Consolidated
`turnover and Profit after Tax were Rs. 125,997 million (USD 2.06 billion)
`and Rs. 24,032 million (USD 393 million) respective|y.P|ease visit
`http://www.lu pinwor|d.com for more infonnation.
`
`l
`
`L
`
`Copyright © 2010, Lupin Pharmaceuticals, Inc., All Rights Reserved.
`
`PAGE 1 OF 1
`mp1/www.Iqinprumaoeuicds_oaruaau1rnn
`
`SENJU EXHIBIT 2263
`
`LUPHV V SENJU
`IPR2015011051/1